Edgar S. Cathcart

2.8k total citations
56 papers, 2.3k citations indexed

About

Edgar S. Cathcart is a scholar working on Molecular Biology, Rheumatology and Hematology. According to data from OpenAlex, Edgar S. Cathcart has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Rheumatology and 11 papers in Hematology. Recurrent topics in Edgar S. Cathcart's work include Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Alzheimer's disease research and treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Edgar S. Cathcart is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Alzheimer's disease research and treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Edgar S. Cathcart collaborates with scholars based in United States, Canada and Brazil. Edgar S. Cathcart's co-authors include Alan S. Cohen, Kenneth D. Brandt, Morton Scheinberg, Don L. Goldenberg, David H. Spodick, John B. O’Sullivan, Martha Skinner, Kenneth H. Gabbay, Allan L. Goldstein and John Ward and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Experimental Medicine.

In The Last Decade

Edgar S. Cathcart

55 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar S. Cathcart United States 25 786 669 458 452 270 56 2.3k
Steven N. Emancipator United States 34 646 0.8× 347 0.5× 398 0.9× 957 2.1× 230 0.9× 95 3.0k
Hirokazu Imai Japan 25 623 0.8× 374 0.6× 234 0.5× 376 0.8× 166 0.6× 138 2.4k
A. V. Hoffbrand United Kingdom 40 956 1.2× 1.4k 2.0× 707 1.5× 547 1.2× 255 0.9× 101 4.6k
P. C. Limburg Netherlands 29 490 0.6× 1.3k 2.0× 245 0.5× 956 2.1× 232 0.9× 58 2.9k
Yaacov Matzner Israel 30 1.4k 1.8× 241 0.4× 411 0.9× 679 1.5× 313 1.2× 99 3.1k
Charles M. Plotz United States 12 279 0.4× 440 0.7× 257 0.6× 297 0.7× 136 0.5× 30 2.0k
B. H. Belohradsky Germany 25 509 0.6× 407 0.6× 375 0.8× 958 2.1× 128 0.5× 99 2.4k
Casper Jersild Denmark 31 374 0.5× 470 0.7× 255 0.6× 1.7k 3.7× 231 0.9× 84 3.5k
Leonard S. Goldberg United States 24 167 0.2× 360 0.5× 231 0.5× 551 1.2× 185 0.7× 97 1.7k
Atsuhisa Ueda Japan 28 1.1k 1.3× 514 0.8× 190 0.4× 560 1.2× 176 0.7× 90 2.6k

Countries citing papers authored by Edgar S. Cathcart

Since Specialization
Citations

This map shows the geographic impact of Edgar S. Cathcart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar S. Cathcart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar S. Cathcart more than expected).

Fields of papers citing papers by Edgar S. Cathcart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar S. Cathcart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar S. Cathcart. The network helps show where Edgar S. Cathcart may publish in the future.

Co-authorship network of co-authors of Edgar S. Cathcart

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar S. Cathcart. A scholar is included among the top collaborators of Edgar S. Cathcart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar S. Cathcart. Edgar S. Cathcart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cathcart, Edgar S., et al.. (1999). Diet, amyloid enhancing factor (AEF) and amyloidogenesis: An hypothesis. Amyloid. 6(2). 107–113. 10 indexed citations
2.
Kirschner, Daniel A., et al.. (1998). In VitroAmyloid Fibril Formation by Synthetic Peptides Corresponding to the Amino Terminus of apoSAA Isoforms from Amyloid-Susceptible and Amyloid-Resistant Mice. Journal of Structural Biology. 124(1). 88–98. 33 indexed citations
3.
Hajri, Tahar, et al.. (1998). The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1394(2-3). 209–218. 13 indexed citations
4.
Cathcart, Edgar S., et al.. (1998). Amyloid Enhancing Factor and Dietary Transmission in Accelerated Amyloid A Amyloidosis. Clinical Immunology and Immunopathology. 88(1). 65–69. 23 indexed citations
5.
Cathcart, Edgar S., et al.. (1997). Apolipoprotein E and Apolipoprotein A-1 Knock-Out Mice Readily Develop Amyloid A Protein Amyloidosis. Clinical Immunology and Immunopathology. 85(1). 104–108. 19 indexed citations
6.
Gonnerman, Wayne A., et al.. (1996). The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism. Amyloid. 3(4). 261–269. 19 indexed citations
7.
Cathcart, Edgar S., et al.. (1996). Polymorphism of Acute-Phase Serum Amyloid A Isoforms and Amyloid Resistance in Wild-TypeMus musculus czech. Clinical Immunology and Immunopathology. 81(1). 22–26. 8 indexed citations
8.
Willkens, Robert F., H. James Williams, John Ward, et al.. (1984). Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic Arthritis. Arthritis & Rheumatism. 27(4). 376–381. 219 indexed citations
9.
Williams, H. James, John Ward, James C. Reading, et al.. (1983). Low‐Dose D‐Penicillamine Therapy in Rheumatoid Arthritis. Arthritis & Rheumatism. 26(5). 581–592. 72 indexed citations
10.
Scheinberg, Morton & Edgar S. Cathcart. (1976). Comprehensive study of humoral and cellular immune abnormalities in 26 patients with systemic amyloidosis. Arthritis & Rheumatism. 19(2). 173–182. 11 indexed citations
11.
Silverman, Stuart L., et al.. (1976). Monocyte involvement in PHA induced cytotoxicity of chicken erythrocytes in man. Cellular Immunology. 22(1). 93–97. 11 indexed citations
12.
Scheinberg, Morton, et al.. (1976). The heterogeneity of leukemic reticuloendotheliosis, “hairy cell leukemia”. Evidence for its monocytic origin. Cancer. 37(3). 1302–1307. 53 indexed citations
13.
Scheinberg, Morton, et al.. (1975). Surface characteristics of synovial fluid and peripheral blood lymphocytes in inflammatory arthritis. Arthritis & Rheumatism. 18(4). 297–304. 27 indexed citations
14.
Goldenberg, Don L., Kenneth D. Brandt, Alan S. Cohen, & Edgar S. Cathcart. (1975). Treatment of septic arthritis. Arthritis & Rheumatism. 18(1). 83–90. 167 indexed citations
15.
Skinner, Martha, Edgar S. Cathcart, Alan S. Cohen, & Merrill D. Benson. (1974). ISOLATION AND IDENTIFICATION BY SEQUENCE ANALYSIS OF EXPERIMENTALLY INDUCED GUINEA PIG AMYLOID FIBRILS. The Journal of Experimental Medicine. 140(3). 871–876. 56 indexed citations
16.
Scheinberg, Morton & Edgar S. Cathcart. (1974). B cell and T cell lymphopenia in systemic lupus erythematosus. Cellular Immunology. 12(2). 309–314. 84 indexed citations
17.
Cathcart, Edgar S. & John B. O’Sullivan. (1970). A New Hemagglutination Test for Rheumatoid Factors. American Journal of Clinical Pathology. 54(2). 209–213. 4 indexed citations
18.
Cathcart, Edgar S. & Alan S. Cohen. (1966). The relation between isolated human amyloid fibrils and human gamma-globulin and its subunits.. PubMed. 96(2). 239–44. 22 indexed citations
19.
Cohen, Alan S., et al.. (1963). Correlation between Rheumatic Diseases and Rh Blood Groups. Nature. 200(4912). 1215–1215. 8 indexed citations
20.
Cathcart, Edgar S. & David H. Spodick. (1962). Rheumatoid Heart Disease. New England Journal of Medicine. 266(19). 959–964. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026